Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?

被引：64

作者：

Cuculi, F. ^{[1
]}

Lim, C. C. S. ^{[1
]}

Banning, A. P. ^{[1
]}

机构：

[1] Oxford Radcliffe Hosp, Dept Cardiol, Oxford, England

来源：

HEART | 2010年 / 96卷 / 10期

关键词：

CREATINE-KINASE-MB; INTRACORONARY BETA-BLOCKER; STATIN THERAPY; UNFRACTIONATED HEPARIN; UNIVERSAL DEFINITION; RANDOMIZED-TRIAL; CLINICAL-TRIAL; TROPONIN-T; CLOPIDOGREL PRETREATMENT; ANTIPLATELET THERAPY;

D O I：

10.1136/hrt.2009.186189

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Periprocedural myocardial injury (PMI) is common after percutaneous coronary intervention (PCI). Periprocedural infarction (myocardial infarction type 4a) occurs after at least 10% of PCI procedures and has an impact on long-term prognosis. Measurement of biomarkers to allow assessment of PMI is an important tool for clinical and research purposes and should be routine after every PCI (troponin I or T and CK-MB). The importance of oral and intravenous antiplatelet agents and other drugs which have been proven to reduce PMI is discussed.

引用

页码：736 / 740

页数：5

共 66 条

[61] Effect of Two-Day Atorvastatin Pretreatment on the Incidence of Periprocedural Myocardial Infarction Following Elective Percutaneous Coronary Intervention: A Single-Center, Prospective, and Randomized Study [J].

Veselka, Josef ;

Zemanek, David ;

Hajek, Petr ;

Maly, Martin ;

Adlova, Radka ;

Martinkovicova, Lucie ;

Tesar, David .

AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (05) :630-633

[62] Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes [J].

Wallentin, Lars ;

Becker, Richard C. ;

Budaj, Andrzej ;

Cannon, Christopher P. ;

Emanuelsson, Hakan ;

Held, Claes ;

Horrow, Jay ;

Husted, Steen ;

James, Stefan ;

Katus, Hugo ;

Mahaffey, Kenneth W. ;

Scirica, Benjamin M. ;

Skene, Allan ;

Steg, Philippe Gabriel ;

Storey, Robert F. ;

Harrington, Robert A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11) :1045-1057

[63] Distal myocardial protection during percutaneous coronary intervention with an intracoronary β-blocker [J].

Wang, FW ;

Osman, A ;

Otero, J ;

Stouffer, GA ;

Waxman, S ;

Afzal, A ;

Anzuini, A ;

Uretsky, BF .

CIRCULATION, 2003, 107 (23) :2914-2919

[64] Clopidogrel pre-treatment in stable angina:: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI?: A randomized multicentre trial PRAGUE-8 [J].

Widimsky, Petr ;

Motovska, Zuzana ;

Simek, Stanislav ;

Kala, Petr ;

Pudil, Radek ;

Holm, Frantisek ;

Petr, Robert ;

Bilkova, Dana ;

Skalicka, Hana ;

Kuchynka, Petr ;

Poloczek, Martin ;

Miklik, Roman ;

Maly, Marek ;

Aschermann, Michael .

EUROPEAN HEART JOURNAL, 2008, 29 (12) :1495-1503

[65] Prasugrel versus clopidogrel in patients with acute coronary syndromes [J].

Wiviott, Stephen D. ;

Braunwald, Eugene ;

McCabe, Carolyn H. ;

Montalescot, Gilles ;

Ruzyllo, Witold ;

Gottlieb, Shmuel ;

Neumann, Franz-Joseph ;

Ardissino, Diego ;

De Servi, Stefano ;

Murphy, Sabina A. ;

Riesmeyer, Jeffrey ;

Weerakkody, Govinda ;

Gibson, C. Michael ;

Antman, Elliott M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20) :2001-2015

[66]

1997, LANCET, V349, P1422

← 1 2 3 4 5 6 7 →